uu.seUppsala universitets publikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Repetitive use of levosimendan in advanced heart failure: need for stronger evidence in a field in dire need of a useful therapy
Univ Klin Innsbruck, Innsbruck, Austria..
Rehabil Zentrum Grossgmain, Salzburg, Austria..
Klinikum Dortmund Mitte, Dortmund, Germany..
HM Broggi, Barcelona, Spain..
Vise andre og tillknytning
2017 (engelsk)Inngår i: International Journal of Cardiology, ISSN 0167-5273, E-ISSN 1874-1754, Vol. 243, s. 389-395Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Patients in the latest stages of heart failure are severely compromised, with poor quality of life and frequent hospitalizations. Heart transplantation and left ventricular assist device implantation are viable options only for a minority, and intermittent or continuous infusions of positive inotropes may be needed as a bridge therapy or as a symptomatic approach. In these settings, levosimendan has potential advantages over conventional inotropes (catecholamines and phosphodiesterase inhibitors), such as sustained effects after initial infusion, synergy with beta-blockers, and no increase in oxygen consumption. Levosimendan has been suggested as a treatment that reduces re-hospitalization and improves quality of life. However, previous clinical studies of intermittent infusions of levosimendan were not powered to show statistical significance on key outcome parameters. A panel of 45 expert clinicians from 12 European countries met in Rome on November 24-25, 2016 to review the literature and envision an appropriately designed clinical trial addressing these needs. In the earlier FIGHT trial (daily subcutaneous injection of liraglutide in heart failure patients with reduced ejection fraction) a composite Global Rank Score was used as primary end-point where death, re-hospitalization, and change in N-terminalprohormone-brain natriuretic peptide level were considered in a hierarchical order. In the present study, we tested the same end-point post hoc in the PERSIST and LEVOREP trials on oral and repeated i.v. levosimendan, respectively, and demonstrated superiority of levosimendan treatment vs placebo. The use of the same composite end-point in a properly powered study on repetitive levosimendan in advanced heart failure is strongly advocated.

sted, utgiver, år, opplag, sider
2017. Vol. 243, s. 389-395
Emneord [en]
Advanced heart failure, Levosimendan, Intermittent, Repetitive, Clinical trial, Composite end-point
HSV kategori
Identifikatorer
URN: urn:nbn:se:uu:diva-333061DOI: 10.1016/j.ijcard.2017.05.081ISI: 000406038100076PubMedID: 28571618OAI: oai:DiVA.org:uu-333061DiVA, id: diva2:1155987
Tilgjengelig fra: 2017-11-10 Laget: 2017-11-10 Sist oppdatert: 2017-11-10bibliografisk kontrollert

Open Access i DiVA

fulltext(346 kB)182 nedlastinger
Filinformasjon
Fil FULLTEXT01.pdfFilstørrelse 346 kBChecksum SHA-512
b5a780dad16f0fc2af6f8d620a0d717a75243998b65191ffc39ed58f9e4f62e55eb4a1096574e632e4e0809644c8f21c26d0af9424ec779678b937c04fb429a1
Type fulltextMimetype application/pdf

Andre lenker

Forlagets fulltekstPubMed

Personposter BETA

Wikström, Gerhard

Søk i DiVA

Av forfatter/redaktør
Wikström, Gerhard
Av organisasjonen
I samme tidsskrift
International Journal of Cardiology

Søk utenfor DiVA

GoogleGoogle Scholar
Totalt: 182 nedlastinger
Antall nedlastinger er summen av alle nedlastinger av alle fulltekster. Det kan for eksempel være tidligere versjoner som er ikke lenger tilgjengelige

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 186 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf